CLINICAL_TRIALS
trial_result
· 2017-08-29
Clinical Trial Update: Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD [Phase 4]
Summary
A Phase 4 clinical trial evaluated roflumilast for effects on bone metabolism markers and endothelial function in chronic obstructive pulmonary disease; results…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Pittsburgh | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED | Results posted: 2017-08-29